`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Paper No. 97
`Filed: December 6, 2018
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`ACRUX DDS PTY LTD., ACRUX LIMITED, and
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioners,
`
`v.
`
`KAKEN PHARMACEUTICAL CO., LTD. and
`VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
`Patent Owner.
`
`
`
`Case: IPR2017-001901
`U.S. Patent No. 7,214,506
`
`
`
`PATENT OWNER’S SIXTH UPDATED MANDATORY NOTICES
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1 Case IPR2017-01429 has been joined with the instant proceeding.
`
`
`
`Kaken Pharmaceutical Co., Ltd. and Bausch Health Companies Inc.
`
`Case IPR2017-00190
`Patent No. 7,214,506
`
`
`(formerly known as Valeant Pharmaceuticals International, Inc.) (collectively
`
`“Patent Owner”) provide the following updated mandatory notices pursuant to 37
`
`C.F.R. § 42.8 in order to notify the Board of the designation of Trenton A. Ward as
`
`additional back-up counsel from Finnegan, Farabow, Garrett & Dunner, LLP.
`
`Lead counsel:
`
`Back-up counsel:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`John D. Livingstone
`Reg. No. 59,613
`john.livingstone@finnegan.com
`Finnegan, Henderson, Farabow,
` Garrett & Dunner, L.L.P.
`271 17th Street, NW, Suite 1400
`Atlanta, GA 30363-6209
`Tel: 404-653-6400
`Fax: 404-653-6444
`
`Naoki Yoshida
`Reg. No. 48,108
`naoki.yoshida@finnegan.com
`Finnegan, Henderson, Farabow,
` Garrett & Dunner, L.L.P.
`901 New York Ave., NW
`Washington, DC 20001-4413
`Tel: 202-408-4000
`Fax: 202-408-4400
`
`Toan P. Vo
`Reg. No. 43,225
`toan.vo@bausch.com
`Bausch Health Companies Inc.
`1400 N. Goodman Street
`Rochester, New York 14609
`Tel: 585-413-6675
`Fax: 585-338-8706
`
`1
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2017-00190
`Patent No. 7,214,506
`
`Anthony Hartmann
`Reg. No. 43,662
`anthony.hartmann@finnegan.com
`Finnegan, Henderson, Farabow,
` Garrett & Dunner, L.L.P.
`901 New York Ave., NW
`Washington, DC 20001-4413
`Tel: 202-408-4000
`Fax: 202-408-4400
`
`Barbara R. Rudolph
`(admitted pro hac vice)
`barbara.rudolph@finnegan.com
`Finnegan, Henderson, Farabow,
` Garrett & Dunner, L.L.P.
`901 New York Ave., NW
`Washington, DC 20001-4413
`Tel: 202-408-4000
`Fax: 202-408-4400
`
`Trenton A. Ward
`Reg. No. 59,157
`trenton.ward@finnegan.com
`Finnegan, Henderson, Farabow,
` Garrett & Dunner, L.L.P.
`271 17th Street, NW, Suite 1400
`Atlanta, GA 30363-6209
`Tel: 404-653-6400
`Fax: 404-653-6444
`
`2
`
`
`
`
`
`Dated: December 6, 2018
`
`Case IPR2017-00190
`Patent No. 7,214,506
`
`Respectfully submitted,
`
`
`
`By: / John D. Livingstone /
`John D. Livingstone
`Reg. No. 59,613
`FINNEGAN, HENDERSON, FARABOW,
` GARRETT & DUNNER, LLP
`271 17th Street, NW, Suite 1400
`Atlanta, GA 30363-6209
`404-653-6400
`
`Lead Counsel for Patent Owner
`
`3
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Case IPR2017-00190
`Patent No. 7,214,506
`
`The undersigned certifies that a copy of the foregoing Patent Owner’s
`
`Sixth Updated Mandatory Notices was served electronically via email on
`
`December 6, 2018, in its entirety on the following:
`
`Tara M. Raghavan
`Steven J. Birkos
`William A. Rakoczy
`Joseph T. Jaros
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`traghavan@rmmslegal.com
`sbirkos@rmmslegal.com
`wrakoczy@rmmslegal.com
`jjaros@rmmslegal.com
`
`Teresa Stanek Rea
`Shannon M. Lentz
`Crowell & Moring LLP
`Intellectual Property Group
`1001 Pennsylvania Ave., NW
`Washington, DC 20004-2595
`trea@crowell.com
`slentz@crowell.com
`
`Tyler C. Liu
`Argentum Pharmaceuticals, LLC
`tliu@agpharm.com
`
`
`
`
`
`By: / John D. Livingstone /
`John D. Livingstone
`Reg. No. 59,613
`
`
`
`
`
`